Research, development and manufacturing of biomedical and pharmaceutical applications, specializing in intrauterine and vaginal drug delivery systems. APCOR R&M uses cutting edge technologies and materials to develop new drug delivery systems. Leveraging our extensive knowhow and knowledge in the field of intrauterine and vaginal drug delivery parmaceuticals and materials, we help our partners in developing new and innovative controlled release systems or improve existing release systems. Wildemeersch continued working on new intrauterine approaches and treatment systems based on polymeric drug delivery. Wim Thielemans at the University of Leuven (KULAK), developing sustainable and innovative materials. APCOR R&M can provide all of these and help build the future of controlled release systems for intrauterine and vaginal drug delivery. Partnering with APCOR R&M provides your company with expertise in:.
Ghent, Belgium
1-10 Employees
Working industry
Pharmaceuticals
Type of company
-
Locations
1 Headquarter
Specialised areas
Pharmaceuticals
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Belgium
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
APCOR R&M operates in 1 country around the world
Get an overview of the locations of APCOR R&M
Location
Country
State
City
Headquarter
Belgium
East Flanders
Ghent
Some frequent questions that have been asked about APCOR R&M
Where is APCOR R&M located?
The company headquarter of APCOR R&M is located in Ghent, East Flanders, Belgium. It's worth noting, that the company may have more locations
How many employees does APCOR R&M approximately have?
As of the latest available information APCOR R&M has around 1-10 employees worldwide.
In which industries does APCOR R&M mainly work?
The company APCOR R&M has it's main focus in the industries of Pharmaceuticals
Check out some interesting alternative companies to APCOR R&M
VLE Therapeutics
Dublin, Ireland
51-100 Employees
2021
And as it has grown, it has also evolved, leading to the creation of VLE, which is hyper-accelerating the path of specialized medicines to market. Here is a brief overview of our story. From the very beginning, our vision has been to revolutionize CMC practices through science and innovation. We quickly made a name for ourselves by providing innovative solutions to some of the most complex and chronic problems in process development. APC’s first research project in 2011 solved a manufacturing throughput problem for a medicine that treated which area of illness? Since 2011, APC has been creating innovative solutions for medicines that treat and prevent all kinds of illnesses. From process development through manufacturing, clients have total clarity with iACHIEVE, our collaborative knowledge management platform for ongoing and transparent communication and robust digital documentation. An Taoiseach Micheál Martin visited visited APC and VLE to tour our state-of-the-art facility, meet our team of world-class scientists and manufacturing engineers, and promote Ireland’s global standing.
ACM Biosciences AG
Basel, Switzerland
11-50 Employees
2020
We are pioneering next next-generation polymer-based delivery technology platform that is able to deliver multiple drug payloads by targeting specific tissues or cells and potentially overcome well-known challenges faced by lipid nanoparticle-based products. At ACM Biolabs, we are developing innovative medicines using our targeted ATP™ delivery platform. At ACM Biolabs we are driven to change the status quo of limited therapeutic applications offered by lipid-based delivery. We are developing diverse treatments with multiple drug modalities with our modular ATPTM platform. We are currently building a high quality and motivated team to develop our polymer-based delivery technology and bring innovative medicines to patients with high unmet medical need. We want to change the status quo of lipid-based targeted delivery of various drug payloads which is limiting its broader therapeutic applications. These ACMs are composed of block co-polymers to create nano delivery carriers. ACM Biolabs’ Tunable Platform (ATP™) is a polymer/lipid hybrid, non-viral delivery platform that offers the flexibility to deliver multiple payloads including oligonucleotides, small molecules, proteins, and mRNA.
Amarin Technologies S.A.
Buenos Aires, Argentina
11-50 Employees
1996
We are a professional partner for your pharmaceutical product development projects, serious and reliable, confirmed by over 30 years of remarkable experience. Amarin Technologies is a duly organized Argentinean company settled in Buenos Aires, engaged in the development and formulation of topical and transdermal pharmaceutical products using its proprietary drug delivery technologies and know-how in order to offer both innovative formulations of well-established drugs or generic versions of marketed products. With R&D, manufacturing, and clinical research capabilities, we own a 1200 sqm state-of-the-art manufacturing plant for transdermal systems involving all operations (mixing, coating, slitting, cutting, pouching and labelling), where our experienced team coordinates and manages the project planning and the product development programs. Amarin is an Argentine company established in the City of Buenos Aires. Formulations and manufacturing of fentanyl patch transferred to EU (LTS & IBSA). We offer expertise and experience, together with flexibility and the ability to adapt to your needs. Committed to provide more people with access to a better quality of life, through high-performance pharmaceutical products that we develop in Latin America and for the world.
APCER Life Sciences
London, United Kingdom
501-1000 Employees
2007
What makes APCER Life Sciences different is the way we work together with our clients. On the other hand, we stand ready and able to deliver a complete outsourced solution, across multiple continents, under the tightest of timeframes. Every client surveyed said that they would highly recommend APCER as a service provider and viewed APCER favorably compared to large CROs and other specialty firms. We offer customized solutions to our clients through our flexible operational models, strong governance and collaborative approach. APCER Life Sciences is part of the APC Group, a global provider of active pharmaceutical ingredients (APIs) with an unblemished reputation for quality and support around the world. APC was founded in 1987 in Hong Kong by APCER’s Chairman, Ravi Menon. As Asian manufacturers increased the quality of their products, APC Group was well positioned to provide APIs and finished formulations from India and China to the West and opened additional offices in Vietnam and Kazakhstan. APC also opened an office in Boston, MA, US, to provide regulatory, product selection, and consulting services to help its customers bridge the gap between China/India and the United States.
APR Applied Pharma Research s.a.
Balerna, Switzerland
51-100 Employees
1990
Discover who we are and our partners global network, as well as learn more about our people. Learn more about our products and how they provide innovative solutions for patiens' unmet needs. Welcome to APR Applied Pharma Research s.a.We are a wholly owned subsidiary of the publicly traded company Relief Therapeutics Holding AG (SIX: RLF.SW, OTCQB: RLFTF, OTCQB: RLFTY as US ADR). We market our products directly through our own sale and marketing teams in selected countries of Europe. APR combines drug development expertise with proprietary drug delivery technologies to deliver to patients suffering from rare diseases with solutions meaningfully improving their life and empowering caregivers with better ways to manage such rare diseases. APR has a balanced portfolio of revenue-generating branded products marketed in all major markets, combined with a compelling pipeline of innovative products at different stages of development, specifically in the treatment of rare recessive metabolic disorders, rare dermatological and ocular diseases. Using various delivery technologies, APR has also developed some Category OTC Healthcare Brands such as Halykoo® and SwitzAGE™. APR provides a wide range of services for the pharmaceutical industry on a contract basis and on a fee for service basis: research and development services with complete supervision, management and execution of the entire project, development of oral and topical formulations and customized drug delivery technologies.
DIVERSA Technologies
Santiago de Compostela, Spain
1-10 Employees
2022
Working with pharma and biotech companies, we identified a common need for delivery solutions in drug development. Overcoming biological barriers is a crucial step to produce efficient pharmaceutical products. To improve patients’ lives by opening up new opportunities for innovative medicines.